DNAAF8: A Potential Drug Target and Biomarker for Neuronal Communication

Target Name: DNAAF8

NCBI ID: G146562

DNAAF8

DNAAF8: A Potential Drug Target and Biomarker for Neuronal Communication

Introduction

The nervous system is a complex and intricate network that enables the development of various physiological and behavioral functions. The communication between neurons is a critical aspect of this network, and the regulation of this communication is tightly controlled by a series of proteins. One of these proteins is DNAAF8, also known as dynein axonemal-associated protein 1. DNAAF8 is a key regulator of the microtubules, which are the structural scaffolding of the neuron and play a crucial role in the transmission of nerve impulses.

DNAAF8 functions as a protein that interacts with the microtubules and modulates their stability. It does this by interacting with a variety of different microtubule-associated proteins (MAPs), which in turn influence the dynamics of the microtubules.

The Importance of DNAAF8 in Neuronal Communication

DNAAF8 is a critical regulator of the stability of the microtubules, and its absence or dysfunction can lead to a wide range of neuronal problems, including neurodegenerative diseases. For example, studies have shown that individuals with genetic mutations that affect the DNAAF8 gene have an increased risk of developing Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

In addition to its role in modulating microtubule stability, DNAAF8 is also involved in the regulation of neuronal communication. It has been shown to play a key role in the regulation of synaptic plasticity, which is the ability of the nervous system to adapt and change in response to experience. DNAAF8 has been shown to interact with a variety of different neurotransmitters, including dopamine, which is a well-known neurotransmitter that plays a crucial role in the regulation of motivation and pleasure.

DNAAF8 and Drug Development

DNAAF8 is a drug target that has the potential to treat a wide range of neuronal disorders. Given its role in the regulation of microtubule stability and neuronal communication, DNAAF8 is an attractive target for small molecule inhibitors. Studies have shown that inhibitors of DNAAF8 have the potential to treat a variety of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In addition to its potential therapeutic applications, DNAAF8 is also a biomarker for a variety of neurological disorders. Given its involvement in the regulation of microtubule stability and neuronal communication, DNAAF8 has been shown to be expressed in a variety of different neural tissues and has been used as a biomarker for a wide range of neurological disorders, including neurodegenerative diseases.

Conclusion

In conclusion, DNAAF8 is a protein that plays a crucial role in the regulation of microtubule stability and neuronal communication. Its absence or dysfunction can lead to a wide range of neuronal problems, including neurodegenerative diseases. Given its potential therapeutic applications and biomarker properties, DNAAF8 is an attractive target for small molecule inhibitors. Further research is needed to fully understand the role of DNAAF8 in neuronal communication and its potential as a drug target.

Protein Name: Dynein Axonemal Assembly Factor 8

Functions: In cyliated cells, dynein axonemal particle-specific protein required for deployment of ODA to the axoneme. Interacts with outer dynein arm (ODA) subunits

The "DNAAF8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DNAAF8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets